Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. (AQST) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
aqst · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$12.00
Consensus
$9.00
+128.1% upside
Low
$6.00
Median: $9 · Last Close: $3.94
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$9.00
128.1% upside
High Target
$12
204.2%
Low Target
$6
52.1%
Current Price
$3.94
as of today
Based on analyst price targets, the AQST stock price prediction for the next 12 months ranges from $6 to $12. The consensus AQST price forecast of $9.00 implies 128.1% upside from the current price of $3.94.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.87 | ↓ 1.98% |
1-day model range: $3.84–$3.89. Peak: $3.89 (-1.98%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | +16.8% |
| 2028 | $5 | +27.5% |
| 2029 | $5 | +34.0% |
| 2030 | $5 | +37.7% |
| 2031 | — | +39.8% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AQST · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-10-09 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-09-08 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-06-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-07 | Lake Street | Maintains | Buy→Buy |
| 2024-12-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Aquestive Therapeutics, Inc. (AQST) stock. Of the recent 54 rating actions, 1 were upgrades and 0 were downgrades. 10 analysts currently cover AQST.
Analyst Recommendation Trends
AQST analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$51M
↓ 49.8% YoY
Revenue Next Year
$70M
↑ 39.0% YoY
EPS This Year
$-0.42
EPS Next Year
$-0.44
↑ 5.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast AQST EPS of $-0.42 for the current fiscal year, based on estimates from 4 analysts. The AQST revenue forecast is $51M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AQST stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AQST price target is $9.00 (+128.1% upside), with an analyst consensus of Buy.
The AQST short-term stock prediction for tomorrow is $3.87 (-1.98%). The AQST stock price prediction for 2027 estimates an average of $5. The AQST stock prediction for 2030 projects a range of $5–$6.
Aquestive Therapeutics, Inc. trades on NASDAQ under the ticker AQST. The AQST stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
AQST forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month AQST price target is $9.00, with a high forecast of $12.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies +128.1% potential upside from the current price of $3.94.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.